1. Home
  2. CNM vs MEDP Comparison

CNM vs MEDP Comparison

Compare CNM & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Core & Main Inc.

CNM

Core & Main Inc.

HOLD

Current Price

$50.26

Market Cap

9.0B

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$543.83

Market Cap

13.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNM
MEDP
Founded
1996
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
13.4B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
CNM
MEDP
Price
$50.26
$543.83
Analyst Decision
Buy
Hold
Analyst Count
11
12
Target Price
$60.00
$465.18
AVG Volume (30 Days)
2.5M
277.0K
Earning Date
12-09-2025
10-22-2025
Dividend Yield
N/A
N/A
EPS Growth
7.24
25.36
EPS
2.25
14.32
Revenue
$7,740,000,000.00
$2,358,373,000.00
Revenue This Year
$4.45
$21.48
Revenue Next Year
$4.43
$11.90
P/E Ratio
$22.35
$38.28
Revenue Growth
11.02
13.88
52 Week Low
$43.18
$250.05
52 Week High
$67.18
$626.26

Technical Indicators

Market Signals
Indicator
CNM
MEDP
Relative Strength Index (RSI) 55.83 36.48
Support Level $44.59 $530.96
Resistance Level $50.10 $626.26
Average True Range (ATR) 1.61 18.24
MACD 0.65 -8.14
Stochastic Oscillator 93.62 17.60

Price Performance

Historical Comparison
CNM
MEDP

About CNM Core & Main Inc.

Core & Main is a leading specialty distributor with a focus on water, wastewater, storm drainage, and fire protection products. The company provides solutions to municipalities, private water companies, and professional contractors across municipal, nonresidential, and residential end markets. The company's specialty products and services are used in the maintenance, repair, replacement, and construction of water and fire protection infrastructure.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: